Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vickerman

Showing results (51-60 of 397) with videos related to

Pageof 40
Sort By:
Lancet (London, England)|July 24, 2010
Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are neededLouisa Degenhardt, Bradley Mathers, Peter Vickerman, et al.
Current Opinion in Infectious Diseases|November 3, 2015
Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidenceMatthew Hickman, Daniela De Angelis, Peter Vickerman, et al.
Sexually Transmitted Diseases|May 25, 2006
The importance of context: model projections on how microbicide impact could be affected by the underlying epidemiologic and behavioral situation in 2 African settingsPeter Vickerman, Charlotte Watts, Sinead Delany, et al.
Plos One|August 20, 2011
Optimal control of hepatitis C antiviral treatment programme delivery for prevention amongst a population of injecting drug usersNatasha K Martin, Ashley B Pitcher, Peter Vickerman, et al.
The International Journal on Drug Policy|December 3, 2014
Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modelingPeter Vickerman, Lucy Platt, Emma Jolley, et al.
Sexually Transmitted Infections|October 27, 2009
Using mathematical modelling to estimate the impact of periodic presumptive treatment on the transmission of sexually transmitted infections and HIV among female sex workersPeter Vickerman, Francis Ndowa, Nigel O'Farrell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapyNatasha K Martin, Matthew Hickman, Sharon J Hutchinson, et al.
Plos One|January 4, 2014
How much demand for New HIV prevention technologies can we really expect? Results from a discrete choice experiment in South AfricaFern Terris-Prestholt, Kara Hanson, Catherine MacPhail, et al.
Sexually Transmitted Infections|November 25, 2010
Remodelling core group theory: the role of sustaining populations in HIV transmissionCharlotte Watts, Cathy Zimmerman, Anna M Foss, et al.
Expert Review of Anti-Infective Therapy|September 2, 2014
The HIV care cascade and antiretroviral therapy in female sex workers: implications for HIV preventionElisa Mountain, Michael Pickles, Sharmistha Mishra, et al.
Pageof 40

Showing results (51-60 of 397) with videos related to

Sort By:
Pageof 40
Lancet (London, England)|July 24, 2010
Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are neededLouisa Degenhardt, Bradley Mathers, Peter Vickerman, et al.
Current Opinion in Infectious Diseases|November 3, 2015
Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidenceMatthew Hickman, Daniela De Angelis, Peter Vickerman, et al.
Sexually Transmitted Diseases|May 25, 2006
The importance of context: model projections on how microbicide impact could be affected by the underlying epidemiologic and behavioral situation in 2 African settingsPeter Vickerman, Charlotte Watts, Sinead Delany, et al.
Plos One|August 20, 2011
Optimal control of hepatitis C antiviral treatment programme delivery for prevention amongst a population of injecting drug usersNatasha K Martin, Ashley B Pitcher, Peter Vickerman, et al.
The International Journal on Drug Policy|December 3, 2014
Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modelingPeter Vickerman, Lucy Platt, Emma Jolley, et al.
Sexually Transmitted Infections|October 27, 2009
Using mathematical modelling to estimate the impact of periodic presumptive treatment on the transmission of sexually transmitted infections and HIV among female sex workersPeter Vickerman, Francis Ndowa, Nigel O'Farrell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapyNatasha K Martin, Matthew Hickman, Sharon J Hutchinson, et al.
Plos One|January 4, 2014
How much demand for New HIV prevention technologies can we really expect? Results from a discrete choice experiment in South AfricaFern Terris-Prestholt, Kara Hanson, Catherine MacPhail, et al.
Sexually Transmitted Infections|November 25, 2010
Remodelling core group theory: the role of sustaining populations in HIV transmissionCharlotte Watts, Cathy Zimmerman, Anna M Foss, et al.
Expert Review of Anti-Infective Therapy|September 2, 2014
The HIV care cascade and antiretroviral therapy in female sex workers: implications for HIV preventionElisa Mountain, Michael Pickles, Sharmistha Mishra, et al.
Pageof 40